Hosted on MSN1mon
HoLEP Double-n Technology Promising for Benign Prostatic Hyperplasia
Participants were randomly allocated to standard HoLEP, single-n technology, and innovative double-n technology (groups A, B, and C, respectively). A total of 139 participants completed the study.
Morningstar7d
Andromeda Surgical Announces Strategic Partnerships with Richard Wolf and Quanta System, Accelerating Global Growth and Clinical Development
The system’s first clinical application is Holmium Laser Enucleation of the Prostate (HoLEP), a gold-standard procedure for treating benign prostatic hyperplasia (BPH). However, Andromeda’s ...
manilatimes7d
Andromeda Surgical Announces Strategic Partnerships with Richard Wolf and Quanta System, Accelerating Global Growth and Clinical Development
The system's first clinical application is Holmium Laser Enucleation of the Prostate (HoLEP), a gold-standard procedure for treating benign prostatic hyperplasia (BPH). However, Andromeda's technology ...